文献速递皮肤肿瘤

基底细胞癌亚型与Mohs显微描记手术中组织学确认的亚临床延伸的相关性:一项前瞻性多中心研究

Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
PubMed 文献 · J Am Acad Dermatol · 2022-02-26

这项前瞻性多中心研究纳入美国16家机构的1686例基底细胞癌,由17名Mohs外科医生记录Mohs显微描记手术所需阶段数。结果显示浅表型基底细胞癌的亚临床延伸风险与通常认为「侵袭性」的亚型相当,且是最可能发生亚临床延伸的亚型。

要点

  • 浅表型基底细胞癌的亚临床延伸风险与「侵袭性」亚型相当。
  • 高亚临床延伸风险亚型包括硬斑病样型(2.1阶段)和浸润型(1.9阶段)。
  • 324例(22.0%)从索引活检到最终Mohs阶段发生组织学亚型漂移。

核心结论

  • 浅表型基底细胞癌的亚临床延伸可能性与适当使用标准认为「适合」Mohs手术的「侵袭性」亚型相当。
  • 当组织学亚型漂移发生时,最可能发生亚临床延伸的亚型是浅表型基底细胞癌。

研究设计与样本

  • 前瞻性多中心研究,涉及美国16家不同执业机构的17名Mohs外科医生。
  • 共收集1686例接受Mohs显微描记手术的基底细胞癌病例。
  • 记录患者人口学、肿瘤特征、肿瘤清除所需Mohs阶段数及索引活检和最终Mohs阶段中的基底细胞癌亚型。

主要发现

  • 按各组织学亚型清除肿瘤所需平均Mohs阶段数分析,显示两种不同程度的亚临床延伸(P < .0001)。
  • 高亚临床延伸风险组(平均1.9阶段,标准差1.0)亚型包括:硬斑病样型(2.1)、浸润型(1.9)、异型性(1.9)、混合型(1.8)、浅表型(1.8)。
  • 低亚临床延伸风险组(平均1.6阶段,标准差0.9)亚型包括:基底鳞状型(1.6)、微结节型(1.6)、结节型(1.6)和未指定型(1.5)。
  • 324例(22.0%)从索引活检到最终Mohs阶段出现组织学亚型漂移或亚型改变。
  • 浅表型基底细胞癌是唯一从索引活检到最终Mohs阶段患病率增加的亚型(从16.0%增至25.8%;P < .0002)。

关键数值与推荐

  • 高亚临床延伸风险组平均Mohs阶段数1.9(标准差1.0),低风险组1.6(标准差0.9)。
  • 浅表型基底细胞癌在最终Mohs阶段的患病率较索引活检增加(16.0% vs 25.8%;P < .0002)。

局限性

  • 索引活检的组织学亚型可能不能代表所有存在的组织学亚型,导致采样偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditionally "aggressive" histologic subtypes (HSs) of basal cell carcinoma (BCC) are more likely to quantitatively exhibit subclinical extension (SCE), requiring more stages during Mohs micrographic surgery (MMS) and, therefore, larger margins upon excision. However, the tendency for SCE has never been compared between HSs of BCC in a prospective manner. OBJECTIVE: To prospectively correlate the HS of BCC with the likelihood of SCE as defined by the number of MMS stages required to clear the tumor. METHODS: In a prospective, multicenter study involving 17 Mohs surgeons in 16 different practices across the United States, data regarding 1686 cases of BCC undergoing MMS were collected. Patient demographics, tumor characteristics, number of MMS stages required for tumor clearance, and specific BCC subtypes noted on both index biopsy and the final MMS stage were recorded. RESULTS: Analysis of the average number of MMS stages for each HS required to clear tumor revealed 2 distinct degrees of SCE (P < .0001): high (higher than average) risk of SCE (1.9 stages, 1.0 SD) and low (lower than average) risk of SCE (1.6 stages, 0.9 SD). Subtypes of BCC within the high category were morpheaform (2.1), infiltrative (1.9), metatypical (1.9), mixed (1.8), and superficial (1.8). The low category included BCC subtypes of basosquamous (1.6), micronodular (1.6), nodular (1.6), and unspecified (1.5). Three hundred twenty-four cases (22.0%) manifested HS drift or a change in subtype from index biopsy to the final MMS stage. Superficial BCC was the only subtype that showed an increase in prevalence from index biopsy to the final MMS stage (from 16.0% to 25.8%; P < .0002). LIMITATIONS: HSs from index biopsy may not be representative of all HSs present, resulting in sampling bias. CONCLUSION: SCE of superficial BCC was as likely as SCE of BCC subtypes that are considered "aggressive" and are deemed "appropriate" for MMS by the appropriate use criteria. Our study also found that when HS drift occurs, the most likely subtype to extend subclinically is superficial BCC.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Lim GF, Perez OA, Zitelli JA, et al. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study. J Am Acad Dermatol. 2022. PMID: 35231546. doi:10.1016/j.jaad.2022.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。